Conference Coverage

Highlights From the 65th ASH Annual Meeting and Exposition

Long-term Bleeding Protection, Sustained FIX Activity, Reduction of FIX Consumption, and Safety of Hemophilia B Gene Therapy

Long-term Bleeding Protection, Sustained FIX Activity, Reduction of FIX Consumption, and Safety of Hemophilia B Gene Therapy

Steven W. Pipe, MD
WATCH
Updates from the GENEr8-1 Trial

Bleeding Outcomes in Participants With Factor VIII Activity

Johnny Mahlangu, BSc, MBBCh, MMed, FCPath

WATCH
HIV Comorbid Infection and Liver-directed AAV-Based Gene Therapy in Adults With Severe and Moderately Severe Hemophilia B

HIV Comorbid Infection and Liver-directed AAV-Based Gene Therapy in Adults With Severe and Moderately Severe Hemophilia B

Steven W. Pipe, MD

WATCH
Image

Please enable the javascript to submit this form

Supported by educational grants from BioMarin, CSL Behring, Pfizer and Spark Therapeutics

Essential SSL